Patents by Inventor Birgit Bossenmaier

Birgit Bossenmaier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL THIOETHER DERIVATIVES
    Publication number: 20050267179
    Abstract: Objects of the present invention are the compounds of formula (I) their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: May 18, 2005
    Publication date: December 1, 2005
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Thomas Friess, Lothar Kling, Ulrike Reiff, Edgar Voss
  • Novel benzylether derivatives
    Publication number: 20050267178
    Abstract: Objects of the present invention are the compounds of formula (I) their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: May 18, 2005
    Publication date: December 1, 2005
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Thomas Friess, Christian Geletneky, Guy Georges, Irene Kolm, Edgar Voss
  • Novel diazine derivatives
    Publication number: 20050222228
    Abstract: The present invention provides compounds of formula (I): their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: March 31, 2005
    Publication date: October 6, 2005
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Wolfgang Jenni, Matthias Rueth, Edgar Voss
  • Novel ether derivatives
    Publication number: 20050209290
    Abstract: The present invention provides the compounds of formula (I) their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: March 17, 2005
    Publication date: September 22, 2005
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Thomas Friess, Ulrike Reiff, Edgar Voss
  • Novel oxidized thioether derivatives
    Publication number: 20050203064
    Abstract: The present invention provides the compounds of formula I their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: March 4, 2005
    Publication date: September 15, 2005
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Thomas Friess, Lothar Kling, Matthias Rueth, Edgar Voss
  • Novel pentafluorosulfanyl compounds
    Publication number: 20050197370
    Abstract: The present invention provides the compounds of formula I-A their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: March 4, 2005
    Publication date: September 8, 2005
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Guy Georges, Matthias Rueth, Edgar Voss
  • Novel arylazole derivatives, their manufacture and use as pharmaceutical agents
    Publication number: 20050124670
    Abstract: There are presented compounds of formula (I) their pharmaceutically acceptable salts, enantiomeric forms thereof, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: October 15, 2004
    Publication date: June 9, 2005
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Ulrike Reiff, Matthias Rueth, Edgar Voss
  • Novel oxazoles, their manufacture and use as pharmaceutical agents
    Publication number: 20050038091
    Abstract: The present invention relates to novel oxazoles of formula (I) their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: August 3, 2004
    Publication date: February 17, 2005
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Ulrike Reiff, Matthias Rueth, Edgar Voss
  • Aniline derivatives, their manufacture and use as pharmaceutical agents
    Publication number: 20040254217
    Abstract: Compounds of formula (I) 1
    Type: Application
    Filed: April 28, 2004
    Publication date: December 16, 2004
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Ulrike Reiff, Matthias Rueth, Edgar Voss
  • Oxazole derivatives
    Publication number: 20040209933
    Abstract: The present invention 1 includes compounds of formula (I), 1
    Type: Application
    Filed: March 25, 2004
    Publication date: October 21, 2004
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Thomas Friess, Bernhard Goller, Matthias Rueth, Edgar Voss
  • Methods for identifying tumors that are responsive to treatment with anti-ErbB2 antibodies
    Publication number: 20040106161
    Abstract: Tumors are identified as responsive to treatment with anti-HER2 antibodies by detecting the presence of a HER2/HER3 and/or HER2/HER1 protein complex or for HER2 phosphorylation in a sample of tumor cells. Patients suffering from a tumor comprising HER/2/HER1 and/or HER2/HER3 heterodimers and/or HER2 phosphorylation are treated with anti-HER2 antibodies, such as rhuMAb 2C4.
    Type: Application
    Filed: July 14, 2003
    Publication date: June 3, 2004
    Inventors: Birgit Bossenmaier, Hans-Joachim Muller, Hans Koll, Mark X. Sliwkowski, Stephen Michael Kelsey